Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Toxicol Lett ; 266: 42-48, 2017 Jan 15.
Article in English | MEDLINE | ID: mdl-27979718

ABSTRACT

Attention deficit hyperactivity disorder (ADHD) is characterized by behavioral and cognitive symptoms. Longitudinal studies demonstrated that the symptoms remains clinically significant for the majority of ADHD children into adulthood. Furthermore, a population-based birth cohort provided the initial evidence of adult ADHD that lacks a history of childhood ADHD. We previously demonstrated that neonatal exposure to bisphenol A, an environmental chemical caused hyperactivity in the juvenile. Here, we extend to examine other chemical such as rotenone, a dopaminergic toxins. Oral administration of rotenone (3mg/kg) into 5-day-old male Wistar rats significantly caused hyperactivity at adulthood (8∼11 weeks old; p<0.05). It was about 1.3∼1.4-fold more active in the nocturnal phase after administration of rotenone than control rats. Higher dose (16mg/kg) or repeated lower dose of rotenone (1mg/kg/day for 4days) caused hyperactivity in the juvenile. Furthermore, DNA array analyses showed that neonatal exposure to rotenone altered the levels of gene expression of several molecules related to apoptosis/cell cycle, ATPase, skeletal molecule, and glioma. Bivariate normal distribution analysis indicates no correlation in gene expression between a hyperactivity disorder model and a Parkinson's disease model by rotenone. Thus, we demonstrate a rotenone models of ADHD whose onset varies during juvenile and adulthood.


Subject(s)
Akathisia, Drug-Induced/pathology , Gene Expression Regulation, Developmental/drug effects , Rotenone/toxicity , Animals , Animals, Newborn , Brain/drug effects , Brain/pathology , Female , Male , Motor Activity , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Wistar , Substantia Nigra/drug effects , Substantia Nigra/growth & development , Substantia Nigra/metabolism
2.
Toxicol Sci ; 156(1): 109-122, 2017 03 01.
Article in English | MEDLINE | ID: mdl-28013217

ABSTRACT

The nitrile 3,3'-iminodipropionitrile (IDPN) causes a loss of hair cells in the vestibular epithelium of the inner ear in several species of both mammals and nonmammals. It is of interest as a model compound in ototoxicity and vestibular regeneration research, but its effects on the mouse, including the potential relevance of strain and sex differences for susceptibility, have not yet been thoroughly characterized. In this study, we compared the vestibular toxicity of IDPN in dose-response studies (0, 8, 12, 16, and 24 mmol/kg IDPN p.o.) in males and females of 2 different mouse strains (RjOrl:Swiss/CD-1 and 129S1/SvImJ). 3,3'-Iminodipropionitrile caused a dose-dependent loss of vestibular function in all sex and strain groups, as assessed by a specific battery of behavioral tests. However, large differences in systemic toxicity were recorded, with high systemic toxicity in 129S1 mice of both sexes compared to limited effects on the Swiss mice. Both male and female Swiss mice showed a marked increase of hindlimb stride width after exposure. The Swiss, but not the 129S1, mice treated with IDPN showed hyperactivity in the open field. The dose-response relationships in the behavioral effects were matched by the extent of hair cell loss assessed by scanning electron microscopy. Altogether, the data demonstrated prominent strain-dependent differences in the systemic toxicity of IDPN between 129S1 and Swiss mice, in contrast to no differences between the strains and small differences between the sexes in its vestibular toxicity. These results support the use of Swiss mice exposed to IDPN as a mouse lesion model for research in vestibular therapy and regeneration.


Subject(s)
Akathisia, Drug-Induced/pathology , Bilateral Vestibulopathy/chemically induced , Drug Resistance , Hair Cells, Vestibular/drug effects , Nitriles/toxicity , Xenobiotics/toxicity , Administration, Oral , Akathisia, Drug-Induced/physiopathology , Animals , Animals, Outbred Strains , Behavior, Animal/drug effects , Bilateral Vestibulopathy/pathology , Bilateral Vestibulopathy/physiopathology , Dose-Response Relationship, Drug , Exploratory Behavior/drug effects , Female , Gait/drug effects , Hair Cells, Vestibular/pathology , Hair Cells, Vestibular/ultrastructure , Male , Mice , Mice, 129 Strain , Microscopy, Electron, Scanning , Nitriles/administration & dosage , Sex Characteristics , Species Specificity , Toxicity Tests, Acute , Weight Loss/drug effects , Xenobiotics/administration & dosage
3.
Semin Pediatr Neurol ; 21(2): 160-5, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25149954

ABSTRACT

We present the case of a 14-year-old girl with a biphasic course after oxycodone ingestion. Clinically, she had a rapid return to baseline after initial ingestion and presented a week later with new-onset ballism, akathisia, and encephalopathy. Neuroimaging demonstrated bilateral globi pallidi and cerebellar lesions with a relative decrease of metabolite peaks on magnetic resonance spectroscopy. Her movement disorder was treated successfully with valproic acid and clonidine. Her cognitive functioning returned to baseline 3 months after ingestion.


Subject(s)
Akathisia, Drug-Induced , Brain Diseases/chemically induced , Dyskinesia, Drug-Induced , Oxycodone/toxicity , Adolescent , Akathisia, Drug-Induced/diagnostic imaging , Akathisia, Drug-Induced/drug therapy , Akathisia, Drug-Induced/pathology , Akathisia, Drug-Induced/physiopathology , Brain/diagnostic imaging , Brain/pathology , Brain Diseases/diagnostic imaging , Brain Diseases/pathology , Brain Diseases/physiopathology , Dyskinesia, Drug-Induced/diagnostic imaging , Dyskinesia, Drug-Induced/drug therapy , Dyskinesia, Drug-Induced/pathology , Dyskinesia, Drug-Induced/physiopathology , Female , Humans , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Movement Disorders , Tomography, X-Ray Computed
4.
PLoS One ; 7(5): e37058, 2012.
Article in English | MEDLINE | ID: mdl-22590645

ABSTRACT

BACKGROUND: Diacylglycerol kinase (DGK) is an enzyme that phosphorylates diacylglycerol to produce phosphatidic acid. DGKß is one of the subtypes of the DGK family and regulates many intracellular signaling pathways in the central nervous system. Previously, we demonstrated that DGKß knockout (KO) mice showed various dysfunctions of higher brain function, such as cognitive impairment (with lower spine density), hyperactivity, reduced anxiety, and careless behavior. In the present study, we conducted further tests on DGKß KO mice in order to investigate the function of DGKß in the central nervous system, especially in the pathophysiology of attention deficit hyperactivity disorder (ADHD). METHODOLOGY/PRINCIPAL FINDINGS: DGKß KO mice showed attention-deficit behavior in the object-based attention test and it was ameliorated by methylphenidate (MPH, 30 mg/kg, i.p.). In the open field test, DGKß KO mice displayed a decreased response to the locomotor stimulating effects of MPH (30 mg/kg, i.p.), but showed a similar response to an N-methyl-d-aspartate (NMDA) receptor antagonist, MK-801 (0.3 mg/kg, i.p.), when compared to WT mice. Examination of the phosphorylation of extracellular signal-regulated kinase (ERK), which is involved in regulation of locomotor activity, indicated that ERK1/2 activation induced by MPH treatment was defective in the striatum of DGKß KO mice. CONCLUSIONS/SIGNIFICANCE: These findings suggest that DGKß KO mice showed attention-deficit and hyperactive phenotype, similar to ADHD. Furthermore, the hyporesponsiveness of DGKß KO mice to MPH was due to dysregulation of ERK phosphorylation, and that DGKß has a pivotal involvement in ERK regulation in the striatum.


Subject(s)
Attention Deficit Disorder with Hyperactivity , Central Nervous System Stimulants/adverse effects , Corpus Striatum , Diacylglycerol Kinase/genetics , MAP Kinase Signaling System , Methylphenidate/adverse effects , Nerve Tissue Proteins/genetics , Akathisia, Drug-Induced/genetics , Akathisia, Drug-Induced/metabolism , Akathisia, Drug-Induced/pathology , Akathisia, Drug-Induced/physiopathology , Animals , Attention Deficit Disorder with Hyperactivity/genetics , Attention Deficit Disorder with Hyperactivity/metabolism , Attention Deficit Disorder with Hyperactivity/pathology , Attention Deficit Disorder with Hyperactivity/physiopathology , Central Nervous System Stimulants/pharmacology , Corpus Striatum/enzymology , Corpus Striatum/metabolism , Corpus Striatum/pathology , Corpus Striatum/physiopathology , Diacylglycerol Kinase/metabolism , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/genetics , Methylphenidate/pharmacology , Mice , Mice, Knockout , Mitogen-Activated Protein Kinase 3/genetics , Mitogen-Activated Protein Kinase 3/metabolism , Nerve Tissue Proteins/metabolism , Phenotype
5.
Brain Res ; 1395: 30-7, 2011 Jun 13.
Article in English | MEDLINE | ID: mdl-21561602

ABSTRACT

Mast cells are located in the central nervous system (CNS) of many mammals and stress induces their degranulation. We postulated that mast cells are associated with wakefulness and stimulatory tone in the CNS, as reflected by spontaneous motor activity. Because stress also precipitates drug-seeking behavior in cocaine addicts, we also postulated that cocaine manifests its effects through this relationship. We investigated the influence of single and repeated injections of cocaine on circulating corticosterone, motor activity and degranulation of mast cells in both the thalamus and meninges of mice. Mice were subjected to 5 consecutive days of cocaine or saline followed by a single injection of cocaine or saline 11 days later. Spontaneous locomotor activity was measure for 1h after the final injection before death. Neither a single injection nor prior treatment with cocaine increased motor activity compared to saline-injected controls, however, repeated administration of cocaine induced a significant sensitization to its behavioral effect when delivered 11 days later. In mice that received only saline, motor activity correlated positively with mast cell degranulation in the meninges but not in the thalamus. Cocaine, regardless of the treatment schedule, disrupted this correlation. The concentration of corticosterone did not differ amongst groups and did not correlate with either behavior or mast cell parameters in any group. The correlation between behavioral activity and the mast cell degranulation in the meninges suggests that these parameters are linked. The disruptive effect of cocaine on this relationship indicates a role downstream from mast cells in the regulation of motor activity.


Subject(s)
Akathisia, Drug-Induced/pathology , Cell Degranulation/drug effects , Cocaine-Related Disorders/pathology , Cocaine/toxicity , Mast Cells/drug effects , Meninges/drug effects , Akathisia, Drug-Induced/physiopathology , Animals , Cell Degranulation/physiology , Cocaine-Related Disorders/physiopathology , Disease Models, Animal , Dopamine Uptake Inhibitors/toxicity , Drug Administration Schedule , Male , Mast Cells/metabolism , Meninges/cytology , Meninges/physiology , Mice , Mice, Inbred C57BL , Stress, Psychological/pathology , Stress, Psychological/physiopathology
6.
Prog Neuropsychopharmacol Biol Psychiatry ; 33(3): 475-81, 2009 Apr 30.
Article in English | MEDLINE | ID: mdl-19439249

ABSTRACT

BACKGROUND: Pharmacogenetics of tardive dyskinesia and dopamine D3 (DRD3), serotonin 2A (HTR2A), and 2C (HTR2C) receptors has been examined in various populations, but not in Russians. PURPOSE: To investigate the association between orofaciolingual (TDof) and limb-truncal dyskinesias (TDlt) and Ser9Gly (DRD3), -1438G>A (HTR2A), and Cys23Ser (HTR2C) polymorphisms in Russian psychiatric inpatients from Tomsk, Siberia. METHODS: In total, 146 subjects were included. Standard protocols were applied for genotyping. TDof and TDlt were assessed with AIMS items 1-4 and 5-7, respectively. Two-part model, logistic and log-normal regression analyses were applied to assess different variables (e.g., allele-carriership status, age, gender, and medication use). RESULTS: TDlt, but not TDof, exhibited an association with Ser9Gly and Cys23Ser (with 9Gly and 23Ser alleles exhibiting opposite effects). However, -1438G>A was not associated with TDof and Dlt. CONCLUSIONS: This is the first pharmacogenetic report on tardive dyskinesia in Russians. Subject to further replication, our findings extend and support the available data.


Subject(s)
Akathisia, Drug-Induced/genetics , Polymorphism, Genetic/genetics , Receptor, Serotonin, 5-HT2A/genetics , Receptor, Serotonin, 5-HT2C/genetics , Receptors, Dopamine D3/genetics , Adult , Aged , Akathisia, Drug-Induced/classification , Akathisia, Drug-Induced/etiology , Akathisia, Drug-Induced/pathology , Chlorpromazine/adverse effects , Cross-Sectional Studies , Cystine/genetics , Disability Evaluation , Extremities/physiopathology , Face/physiopathology , Female , Gene Frequency , Genotype , Glycine/genetics , Humans , Male , Middle Aged , Models, Statistical , Mouth/physiopathology , Pharmacogenetics , Psychiatric Status Rating Scales , Schizophrenia/drug therapy , Schizophrenia/genetics , Serine/genetics , Severity of Illness Index , Siberia/epidemiology , Siberia/ethnology
7.
Ann N Y Acad Sci ; 1142: 72-84, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18990122

ABSTRACT

This article reviews the current state of knowledge of drug-induced movement disorders (DIMDs) in children. The objective is to aid clinicians who treat children with medications that may induce DIMDs, as well as specialists consulted on DIMDs. As with adults, the most common agents are dopaminergic and dopamine-blocking medications, and prescriptions for these agents have increased markedly in children. Unfortunately, most evidence-based reviews, including those from the Cochrane Collaboration cited here, have few systematic data to analyze. Many publications are small case series. This report attempts to provide useful information, with appropriate caution and discussion of the limitations of what we know.


Subject(s)
Movement Disorders/pathology , Movement Disorders/therapy , Akathisia, Drug-Induced/etiology , Akathisia, Drug-Induced/pathology , Akathisia, Drug-Induced/therapy , Antipsychotic Agents/adverse effects , Child , Dopamine Antagonists/adverse effects , Dyskinesia, Drug-Induced/etiology , Dyskinesia, Drug-Induced/pathology , Dyskinesia, Drug-Induced/therapy , Humans , Movement Disorders/etiology , Psychotropic Drugs/adverse effects
8.
Eur J Neurosci ; 26(7): 1912-24, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17897397

ABSTRACT

Movement disorders such as tremor and akinesia observed in Parkinson's disease have been attributed to dopamine (DA) depletion in the basal ganglia. The changes in subcortical neuronal discharge patterns that follow DA depletion have been a matter of much discussion. Here, we implanted rats with chronic recording electrodes bilaterally in the striatum (CPu) and external globus pallidus (GPe), and induced both acute and repeated DA blockade by administration of high-dose haloperidol. Recordings were made in baseline states, as well as before and after haloperidol injections, which rendered rats akinetic. The immediate physiological effect of pharmacological DA blockade was the development of prominent oscillatory firing in the 6-8 Hz range in both CPu and GPe. Importantly, this oscillatory pattern was not accompanied by consistent changes in the firing rate of either CPu or GPe neurons. Cross-correlation analysis further indicated that neurons within the CPu and GPe fired synchronously after DA blockade. Furthermore, although phase lags between neuronal discharges in the GPe and CPu were uniformly distributed prior to haloperidol administration, CPu significantly lagged GPe discharges after repeated DA blockade. Our results demonstrate that acute DA blockade is sufficient to produce synchronous oscillatory activity across basal ganglia neuron populations, and that prolonged DA blockade results in phase lag changes in pallidostriatal synchrony.


Subject(s)
Action Potentials/drug effects , Akathisia, Drug-Induced , Basal Ganglia/drug effects , Dopamine Antagonists/adverse effects , Haloperidol/adverse effects , Periodicity , Action Potentials/physiology , Akathisia, Drug-Induced/etiology , Akathisia, Drug-Induced/pathology , Akathisia, Drug-Induced/physiopathology , Animals , Basal Ganglia/cytology , Functional Laterality , Male , Neurons/drug effects , Rats , Rats, Sprague-Dawley , Spectrum Analysis , Time Factors
9.
Acta Neurochir Suppl ; 97(Pt 2): 207-14, 2007.
Article in English | MEDLINE | ID: mdl-17691306

ABSTRACT

With the renaissance of stereotactic pallidotomy for Parkinson's disease in 1990s, pallidotomy has become increasingly used as an effective treatment for various manifestations of medically refractory dystonia. More recently, deep brain stimulation of globus pallidus internus (GPi) has been replacing pallidotomy. Although GPi DBS has great promise for treating dystonia, there are some disadvantages. We introduce our experiences in subthalamic nucleus (STN) DBS for primary dystonia and tardive dystonia in this chapter. We propose that STN DBS has the following advantages over GPi DBS: (1) symptomatic improvement is seen immediately after stimulation, allowing us to quickly select the most suitable stimulation parameters; (2) the stimulation parameters for the STN are lower than those used for the GPi, resulting in longer battery life; and (3) STN DBS results in better symptomatic control than GPi DBS in dystonia patients when our STN data is compared to that obtained by others with using the GPi as the target. We suggest that STN DBS may be the most appropriate surgical technique for dystonia.


Subject(s)
Akathisia, Drug-Induced/therapy , Dystonic Disorders/therapy , Subthalamic Nucleus/radiation effects , Akathisia, Drug-Induced/pathology , Deep Brain Stimulation , Dystonic Disorders/pathology , Humans , Subthalamic Nucleus/physiopathology
10.
Mov Disord ; 19(8): 969-72, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15300668

ABSTRACT

The clinical response of a 53-year-old woman with tardive dyskinesia treated with bilateral globus pallidus interna deep brain stimulation is described. At 18 months follow-up, her Burke-Fahn-Marsden Dystonia Rating Scale score fell from 52 (preoperative) to 21 (60% improvement).


Subject(s)
Akathisia, Drug-Induced/therapy , Deep Brain Stimulation , Globus Pallidus/radiation effects , Akathisia, Drug-Induced/pathology , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging/methods , Middle Aged
11.
Drugs Aging ; 5(4): 254-62, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7827396

ABSTRACT

Although antipsychotic drugs are the mainstay of treatment in older patients with schizophrenia, much of the theoretical work underpinning their use is based on evidence gained from younger patients. With respect to dosages, there has been little work comparing plasma concentrations of antipsychotics in older patients with those of younger patients. However, there are well documented changes in the pharmacokinetics of these drugs in the elderly, particularly in their hepatic metabolism and renal excretion. There is also evidence that older patients experience more adverse effects from antipsychotics than younger patients. Such effects include extrapyramidal symptoms, postural hypotension and falls. For these reasons it is recommended that starting doses of antipsychotic drugs in older patients should be in the region of 25 to 50% of that recommended for younger patients, and should be slowly increased. Selection of a particular antipsychotic agent is best made on the basis of individual patient characteristics and the adverse effect profiles of particular drugs.


Subject(s)
Aging/psychology , Antipsychotic Agents/therapeutic use , Schizophrenia/drug therapy , Aged , Aging/metabolism , Akathisia, Drug-Induced/pathology , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/adverse effects , Antipsychotic Agents/pharmacokinetics , Clozapine/therapeutic use , Drug Prescriptions , Dyskinesia, Drug-Induced/pathology , Dystonia/chemically induced , Humans , Parkinson Disease, Secondary/chemically induced , Schizophrenia/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...